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MitochondriaAbstract In this study we scrutinized the association between the A8344G/A3243G mutations and
a 9-bp deletion polymorphism with gestational diabetes mellitus (GDM) in an Asian Indian popu-
lation. The A3243G mutation in the mitochondrial tRNALeu(UUR) causes mitochondrial encepha-
lopathy myopathy, lactic acidosis, and stroke-like episodes (MELAS), while the A8344G
mutation in tRNALys causes myoclonus epilepsy with ragged red ﬁbers (MERRF). We screened
140 pregnant women diagnosed with GDM and 140 non-GDM participants for these mutations
by PCR-RFLP analysis. Both A3243G and A8344G were associated with GDM (A3243:
OR-3.667, 95% CI = 1.001–13.43, p= 0.03; A8344G: OR-11.00, 95% CI = 0.6026–200.8,
p= 0.04). Mitochondrial DNA mutations contribute to the development of GDM. Our results
conclude that mitochondrial mutations are associated with the GDM women in our population.
Thus it is important to screen other mitochondrial mutations in the GDM women.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Gestational diabetes mellitus (GDM) is the most common
metabolic disorder in pregnant women and is characterized
by carbohydrate intolerance of variable severity with onset
or ﬁrst recognition during pregnancy regardless of glycemic
status after delivery (Chen et al., 2000). GDM remains one
of the most common clinical issues faced by obstetricians
(Wang et al., 2013). The risk of developing GDM during
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phisms in the mother and neonates (Petry et al., 2011).
GDM can produce adverse neonatal outcomes including birth
defects, neonatal hypoglycemia, macrosomia, cardiac dysfunc-
tion, and long-term consequences such as increased risk for
obesity, arterial hypertension, and metabolic syndrome (Lee
et al., 2008). In addition, GDM has a high predictive value
for later development of type 2 diabetes mellitus (T2DM) in
the mother. Although insulin resistance is universally observed
in pregnant women with GDM, the cellular mechanisms
underlying this type of insulin resistance are not well-under-
stood (Wang et al., 2013).
In the past decade, many efforts have been made to identify
pathogenic nuclear and mitochondrial mutations in GDM.
Advanced genetic approaches such as genome-wide associa-
tion studies (GWAS) have identiﬁed multiple susceptibility loci
in the pathogenesis of T2DM, many of which, through linkage
scans, candidate gene studies, and GWAS, have also been
shown to have roles in GDM, consistent with the notion that
both types of diabetes share a common pathophysiology.
Mutations in mitochondrial DNA (mtDNA) have been associ-
ated with a wide spectrum of clinical abnormalities, including
neuromuscular disorders, heart failure, diabetes, hearing and
visual loss (Brandon et al., 2005; Jacobs, 2003; Larsson,
2002; Wallace, 2005). More than 50% of these mtDNA muta-
tions are located in 22 mitochondrial tRNA genes, including
tRNALeu(UUR) (Li and Guan, 2010). mtDNA mutations have
been described in association with various diseases, including
T2DM (Li and Guan, 2010; Mathews and Berdanier, 1998;
Duraisamy et al., 2010; Padma et al., 2010). The involvement
of mtDNA in disease pathogenesis could contribute to biased
maternal transmission of certain forms of diabetes.
Mitochondrial diseases are clinically heterogeneous group
of disorders ranging from single-organ to severe multisystemic
diseases (Chae et al., 2004). The mitochondrial tRNALeu(UUR)
gene is a hotspot for pathogenic mutations associated with
mitochondrial diseases with various clinical features. In fact,
21 different point mutations in this gene have been reported.
Among these, the A3243G mutation has been associated with
various types of mitochondrial multisystem disorders, such as
mitochondrial myopathy, encephalopathy, lactic acidosis and
stroke-like episodes (MELAS), maternally inherited diabetes
and deafness (MIDD), myoclonus epilepsy with ragged red
ﬁbers (MERRF), maternally inherited progressive external
ophthalmoplegia (PEO), hypertrophic cardiomyopathy, and
Leigh syndrome (Mkaouar-Rebai et al., 2007).
Cataloged mtDNA mutations include point mutations,
deletions, and duplications, the majority of which affecting
transcription and translation of mtDNA are the main etiolog-
ical factors of most mitochondrial diseases (Viola et al., 2008;
Shen et al., 2011). One such deletion polymorphism involves
the loss of one copy of a 9-bp tandem repeat (CCCCCTCTA)
in the intergenic region of cytochrome c oxidase II (COII)/
mitochondrial TK2 thymidine kinase 2 (MTTK) (Wrischnik
et al., 1987). The ‘‘CCCCCTCTA’’ repeat polymorphism pres-
ent between the 8271 and 8279 nucleotides of mtDNA has
been well investigated in phylogenic population studies.
MERRF is a multisystem mitochondrial disorder deﬁned by
myoclonus, generalized epilepsy, ataxia, and ragged-red ﬁbers
(RRFs) in muscle biopsies (Hirano, 2010). In 1992, an A to G
point mutation at nucleotide position (np) 3243 in
tRNALeu(UUR) was identiﬁed by a large pedigree analysisMIDD, which was later shown to be associated with diabetes
in about 1.5% of the diabetic population worldwide. Subse-
quently, many other mutations in the tRNALeu(UUR) gene
and other mtDNA regions were reported in T2DM (Crispim
et al., 2008).
Maternal inﬂuence on the predisposition to GDM has also
been observed, since mitochondrial transmission is exclusively
maternal and both b-cell dysfunction and decreased insulin
sensitivity have been associated with mtDNA mutations; thus,
defective mtDNA could be a candidate gene for GDM. How-
ever, the 9-bp deletion in combination with the A3243G and
A8344G mutation has also been associated with several dis-
eases including T2DM (Crispim et al., 2008). In this study,
we aimed to explore whether A8344G/A3243G mutations
and the 9-bp deletion inﬂuence the occurrence of GDM in
Asian Indian population.
2. Materials and methodology
2.1. Study design
We recruited 280 pregnant women from two hospitals in
Hyderabad, India. Women without previous diagnosis of glu-
cose intolerance were routinely screened for GDM between 24
and 28 weeks of gestation by a 50-g glucose challenge test
(GCT). This test was considered GCT negative (GCT) if
the plasma glucose concentration was less than 7.8 mmol/L
1 h after glucose intake; otherwise, the patient was diagnosed
as GCT positive (GCT+). These patients were then given a
100-g oral glucose tolerance test (OGTT). Diagnosis of
GDM was based on the criteria set by the American
Diabetes Association (2010). Glucose thresholds were as fol-
lows: fasting, 95 mg/dL; 1 h, 180 mg/dL; 2 h, 165 mg/dL; and
3 h, 145 mg/dL. A diagnosis of GDM was made if two or more
of the values met or exceeded the threshold. Normal glucose
tolerance (NGT) or non-GDM (n= 140) was diagnosed when
all plasma glucose values were below the threshold values.
Based on the above criteria, 140 subjects with GDM and 140
non-GDM participants were recruited. The NGT subjects
were classiﬁed as normal pregnancy controls or non-GDM
(Khan et al., 2014).
2.2. Clinical and biochemical data
Clinical and biochemical data for all subjects were collected
between 24 and 28 weeks of gestation. Clinical data included
age and weight. A family history of T2DM was also
recorded. Body mass index before gestation (pre-BMI) was
calculated according to Quetelet’s equation by using the
weight divided by the square of height (kg/m2). Biochemical
data consisted of fasting blood sugar (FBS) and postprandial
blood glucose (PPBG) levels, as well as the 50-g GCT and
the 100-g OGTT results.
2.3. DNA extraction
Peripheral blood (2 mL) was collected in EDTA tubes. Nucleic
acids were extracted from white blood cells by salting out
extraction (Khan et al., 2015). DNA quantity and quality were
assessed by Nano Drop and gel electrophoresis. DNA was
stored at 80 C. The genotyping was performed at the
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accreditation laboratory), Kamineni Hospitals, Hyderabad,
Telangana, India.
2.4. Analysis of the mitochondrial mutations
Genotyping for the A3242G and A8344G mutations was per-
formed by polymerase chain reaction (PCR) in an Applied
Biosystems thermal cycler. PCR was performed in a 50-lL
volume containing 5 lL of 10· Tris buffer (cat#105878,
Bangalore Genie, Bangalore, India), 4 lL of MgCl2 (25 mM;
cat#METB5 Bangalore Gene, Bangalore, India), 1 lL of each
dNTP (10 mM; cat# Fermentas, Hannover, MD, USA), 1 lL
of each primer (10 pmol; Bioserve Biotechnology, Hyderabad,
India) (Table 1), and 2.5 U Taq polymerase (cat#MME27,
Bangalore Gene, Bangalore, India) as described previously
(Crispim et al., 2008).
A three-step PCR for A3242G was performed as described
(Khan et al., 2015). The initial denaturation at 95 C for 5 min
was followed by 35 cycles of denaturation at 95 C for 30 s,
annealing at 56 C for 30 s for A3242G and 60 C for 30 s
for A8344G, extension at 72 C for 45 s, and a ﬁnal extension
at 72 C for 5 min. The ampliﬁed mutation products were
digested with HaeIII (A3243G; cat#ER 108, MBI Fermentas,
Hannover, MD, USA), and AvaII (A8344G; cat#ER 0312,
MBI Fermentas, Hannover, MD, USA) in a total volume of
20 lL for 2 h at 37 C, then separated by electrophoresis on
12% polyacrylamide gel electrophoresis. Bands were analyzed
and imaged by a gel documentation system (UVI tech docu-
mentation system, Cambridge, UK).
2.5. Statistical analysis
Statistical analysis to determine the odds ratios, Yates correc-
tion, and p values was performed using Openepi for Windows,
version 2.3.1 (Openepi Software, United States). The frequen-
cies of each group in cases and controls (non-GDM) were
compared with Pearson v2/Fisher’s exact test. A p-value less
than 0.05 was considered signiﬁcant. The t-tests were per-
formed with SPSS software version 19.0 (Chicago, USA).
3. Results
3.1. Characteristics of study subjects
The clinical characteristics of GDM patients and non-GDM
subjects are given in Table 2. GDM cases (n= 140) had an
age range of 22–38 years, 31% of them were primigravida,
while 69% were multigravida. The pre-pregnancy BMI range
of the GDM cases was 19.8–35.6 kg/m2 with a mean of
27.08 ± 3.93 kg/m2 and in non-GDM cases the mean was
24.10 ± 3.55 kg/m2 (p= 0.31). FBS values differ signiﬁcantly
between two groups i.e. cases and controls (non-GDMTable 1 Mitochondrial DNA mutations detected by the PCR-RFL
Gene Mutation Amino acid change Nature P
tRNALeu(UUR) A3243G – Heteroplasmic L
tRNALys A8344G – Heteroplasmic Lsubjects) (p= 0.004). In the GDM group, 45% managed their
diabetes with diet and exercise, while 55% of patients required
4–8 units of insulin for the remainder of the prenatal period.
PPBG values were found to be signiﬁcantly high in GDM
cases compared with the non-GDM subjects (p< .0001).
3.2. Detection of the A3243G heteroplasmic mutation
The tRNALeu(UUR) A3243G variant was assessed in all sub-
jects. The variant was found in fourteen subjects: eleven in
GDM cases and three in the non-GDM subjects. There was
a signiﬁcant difference in the frequency of the A3243G
variants (Table 3).
3.3. Detection of the A8344G heteroplasmic mutation
A 200-bp product of tRNALys (A8344G) was digested with
AvaII to yield a 134/66 bp fragment. The frequency of the
A8344G mutation in tRNALys (MERRF) was signiﬁcantly
high in the cases when compared with non-GDM subjects.
Five variants were identiﬁed in the GDM group. Thus, there
was an association between this genotype and GDM after
Yates correction (Table 3).
3.4. 9-bp repeat polymorphism
The COII/MTTK gene contains a 200-bp region with a double
CCCCCTCTA repeat (i.e. CCCCCTCTA–CCCCCTCTA).
Insertion of a third 9-bp repeat yields a 209-bp fragment and
deletion of one of the repeats yields a 191-bp fragment. In this
study, the deletion polymorphism was found in 4.3% of the
GDM patients; the remainder of the GDM patients carried
the double repeat. None carried the insertion genotype. None
of the non-GDM subjects carried an insertion or deletion
genotype; thus, all carried the double repeat (Table 4).
4. Discussion
We studied 280 GDM and non-GDM pregnant women in
Asian Indian subjects to characterize the association between
mitochondrial mutations [tRNALeu(UUR) (A3243G) and the
tRNALys gene (A8344G)/(CCCCCTCTA) polymorphism].
The clinical results showed a signiﬁcant difference in age,
weight, FBS, and PPBG (p< 0.05). The results recommended
that there is a possible association and development of GDM
in women of the Asian Indian population.
The 9-bp deletion was detected in 6% of the GDM patients.
Mitochondrial mutations and GDM suggest that it may have
some pathogenic roles in disease development (Chen et al.,
2000). GDM is a heterogeneous group of disorders with
long-term implications for the mother and fetus. Although
the susceptibility to GDM is genetically determined, the role
of mitochondrial mutations in the etiology of GDM is notP method.
rimers Fragment Annealing temp Enzyme
3029–3048/H3456–3437 501 bp 56 C HaeIII
8278–8305/H8386–8336 200 bp 60 C AvaII
Table 2 Clinical characteristics of the study population.
S. No. Proﬁles GDM (n= 140) non-GDM (n= 140) p Value
1 Age (Years) 22–38 (29.1 ± 4.46) 17–34 (24.6 ± 3.55) 0.02
2 Weight (kg) 69.2 ± 10.43 51.2 ± 6.26 0.0001
3 BMI (kg/m2) 27.0 ± 3.93 24.1 ± 3.55 0.31
4 Mean gestational age 24.9 ± 5.01 NA NA
5 FBS (mg/dL) 121.9 ± 13.21 83.2 ± 10.37 0.004
6 PPBG (mg/dL) 158.8 ± 47.76 112.0 ± 39.70 0.0001
7 Family history 84 (60%) 56 (40%) 0.002
8 Insulin/diet (Rx) 77(55%)/63(45%) NA NA
NA= not analyzed/not applicable.
Table 3 Prevalence of mitochondrial mutations in GDM and non-GDM subjects.
Mutations GDM (n= 140) non-GDM (n= 140) p Value Odds ratio 95% CI
A3243G 7.8% (11/140) 2.1% (3/140) 0.03 3.667 (1.001–13.43)
A8344G 3.6% (5/140) 0 (0/140) 0.04* 11 (0.6026–200.8)
* Indicates Yates correction.
Table 4 Analysis of the 9-bp repeats.
Disease One repeat (deletion) Two repeats Three repeats (insertion)
GDM (n= 140) 6 (4.3%) 134 (95.7%) 0 (0.0%)
non-GDM (n= 140) 0 (0.0%) 140 (100%) 0 (0.0%)
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with human diseases such as T2DM and GDM (Chen et al.,
2000; Vijaya padma et al., 2010). T2DM and GDM share a
common pathophysiology that is characterized by insulin resis-
tance and pancreatic b-cell dysfunction (Bao et al., 2012;
Matharoo et al., 2013).
We found an association between the tested mutations and
GDM, trembling with the previous studies we also found a
similar lack of association in Singaporean women (Chen
et al., 2000). To our knowledge, this is the ﬁrst molecular epi-
demiological study of the association between A3243G,
A8344G, and the 9-bp deletion and GDM in an Asian Indian
women.
Repetitive and insertion/deletion DNA sequences have
been found in nuclear and mtDNA and are associated with
various diseases (Komandur et al., 2011). A 9-bp double
CCCCCTCTA repeat in the intergenic region of MTCO2
and MTTK is polymorphic in an Asian Indian population,
appearing as a single repeat (deletion) or three repeats (inser-
tion) in <3% of the population (Thangaraj et al., 2005).
The 9-bp deletion is more frequent in individuals with mt dis-
eases such as MELAS and MERRF (Lin and Beal, 2006).
Chen et al. (2000) were unable to detect the A3243G muta-
tion in GDM patients. The mtDNA A3243G mutation does
not confer a genetic risk for GDM in Singaporean women;
however, ﬁve mtDNA mutations were identiﬁed in GDM
patients, including T3398C, which might have a functional role
in the development of GDM. Two novel mutations (C3254A
and A3399T) are also worthy of study because the sites of
these mutations appear important for mitochondrial function.
The A3243G mutation was not detected in this prior study,
suggesting it may not majorly contribute to mild forms ofdiabetes such as GDM, although it could lead to the develop-
ment of overt diabetes mellitus by affecting the offspring mito-
chondrial function (Chen et al., 2000).
A3243G mutational studies were performed in pregnant
Taiwanese women (Chou et al., 2004). In this study both the
mother and fetus carried the MELAS-speciﬁc A3243G muta-
tion; however, the mtDNA level of the amniotic ﬂuid did not
signiﬁcantly differ from that of the postnatal peripheral blood
and hair follicles. Chou et al., 2004 concluded that MELAS
syndrome may help in identifying mitochondrial mutations
during pregnancy.
No studies have explored the association between the 9-bp
repeat insertion–deletion polymorphism and GDM. Ours is
the ﬁrst report of this association. We suggest the insertion/
deletion polymorphism in the untranslated region of mtDNA
could have a pathogenic role in the disease, whereas A8343G
and A8344G mutations have a role in GDM.
We identiﬁed six GDM women who carried the deletion
genotype. Of these, ﬁve had a family history of T2DM and
all ﬁve required insulin therapy. One woman was on diet and
had no family history. All the women diagnosed with GDM
were overweight (BMI 25–30), in their mid-30 s, and had very
high fasting glucose (>100 mg/dL) and were examined at a
mean gestational age of 28 weeks. Table 5 lists the demo-
graphic data of the GDM women with the deletion genotype.
Duraisamy et al., 2010 performed a mitochondrial study of
the A3243G variant in South Indian T2DM patients. The var-
iant was identiﬁed in two patients with similar clinical charac-
teristics. They concluded that these mitochondrial mutations
indicate a genetic predisposition to DM in the Coimbatore
South Indian population (Duraisamy et al., 2010). In our
study, we found eleven mutations in the GDM cases and three
Table 5 Characteristics of the GDM cases with the single repeat variant.
S. No. Age BMI (kg/m2) FBS (mg/dL) Family history Gestational age Rx
1 30 26.2 139 Positive 28 Insulin
2 28 29.6 184 Positive 26 Insulin
3 33 29.4 128 Negative 26 Diet
4 31 27.9 121 Positive 28 Insulin
5 25 26.5 175 Positive 26 Insulin
6 29 26.3 110 Positive 32 Insulin
Screening of mitochondrial mutations and insertion–deletion polymorphism 247in the non-GDM subjects. Earlier study by Malecki (2001)
explored the A3243G variant in 129 T2DM subjects and 12
GDM cases in a Polish population. They concluded that
A3243G has no role in diabetes in this population (Malecki,
2001). Another study of GDM by Allan et al. (1997) found
no instances of the A3243G mutation in American women.
Lee and Wei (1997) explored the A3243G and A8344G
mutations in Korean diabetics and found only one instance
of A3243G in a diabetic subject. Otabe et al., 1994 reported
a 0.9% frequency of A3243G in diabetic Japanese and no
instances of A8344G. The A3243G mutation has been studied
in various populations, none of which has shown a signiﬁcant
association with disease, although the mutation was identiﬁed
in all tested population. A8344G was detected in our study, the
results of which were consistent with all the previous studies on
this subject.
5. Conclusion
Our results conclude that mitochondrial mutations are associ-
ated with the GDM women in our population. A3243G;
A8344G and 9-bp repeat have a role in our study with the
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